Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth. | Cancer Lett | 2026 | 41912133 | PubTator, text mining | PubMed |
| Screening and Preliminary Validation of Parthanatos-Related Key Genes in Asthma Using Transcriptomic and Machine Learning Approaches. | J Inflamm Res | 2026 | 41877826 | PubTator, text mining | PubMed |
| Targeting sialic acid metabolism: a therapeutic strategy against gastric cancer driven by WZ35. | Cell Oncol (Dordr) | 2026 | 41870836 | PubTator, text mining | PubMed |
| SAMHD1 depletion restricts SARS-CoV-2 infection by suppressing HNF1-dependent ACE2 expression in lung epithelial cells. | PLoS Pathog | 2026 | 41855156 | PubTator, text mining | PubMed |
| Integrative multi-omics and machine learning reveals the spatial niche distribution and role of CYP27A1+TAMs in immunotherapy response in non-small cell lung cancer. | Front Immunol | 2026 | 41836417 | PubTator, text mining | PubMed |
| Low-Intensity CD66c Expression Orchestrates an Immunosuppressive Niche Promoting Residual Disease in Pediatric ProB Acute Lymphoblastic Leukemia. | Cells | 2026 | 41827869 | PubTator, text mining | PubMed |
| Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility. | Pharmacology | 2026 | 41818350 | PubTator, text mining | PubMed |
| Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders. | Int J Med Sci | 2026 | 41799760 | PubTator, text mining | PubMed |
| S100A14 Facilitates Pancreatic Cancer Progression via S100A16-Mediated p53 Suppression. | Oncol Res | 2026 | 41799516 | PubTator, text mining | PubMed |
| USP1 promotes hepatocellular carcinoma progression by modulating mitophagy via stabilizing MCM3 to regulate the Keap1-Nrf2 axis. | iScience | 2026 | 41797940 | PubTator, text mining | PubMed |
| A novel triaptosis-related prognostic signature to assess the clinical value in HER2-low breast cancer: evidence from clinical cohorts and experimental validation. | Apoptosis | 2026 | 41793564 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
Serum total sialic acid and carcinoembryonic antigen as biomarkers in diagnosis and stratification of oral squamous cell carcinoma, oral submucous fibrosis, and periodontitis: a prospective cross-sectional analytical study. | Saudi Dent J | 2026 | 41784898 | PubTator, text mining | PubMed |
| Proteomic landscape of colorectal cancer liver metastasis: molecular signatures and novel therapeutic targets. | PeerJ | 2026 | 41769411 | PubTator, text mining | PubMed |
| Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. | Front Cell Dev Biol | 2026 | 41768991 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
| Signatures of Pancreatic Ductal Adenocarcinoma Uncovered by Integrative Multi-Omics Analysis. | Cancers (Basel) | 2026 | 41749940 | PubTator, text mining | PubMed |
| Whole blood transcriptomics reveals sepsis mortality-associated changes in neutrophil degranulation. | Am J Respir Cell Mol Biol | 2026 | 41738283 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomics reveal the differentiation drivers of gastric epithelial lineage progression. | Front Immunol | 2026 | 41737224 | PubTator, text mining | PubMed |
| CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis. | J Immunother Cancer | 2026 | 41714114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=2